vs
Cardio Diagnostics Holdings, Inc.（CDIO）与奎斯特诊断（IMDX）财务数据对比。点击上方公司名可切换其他公司
奎斯特诊断的季度营收约是Cardio Diagnostics Holdings, Inc.的320.4倍（$1.1M vs $3.6K）。Cardio Diagnostics Holdings, Inc.同比增速更快（-21.2% vs -23.4%）。Cardio Diagnostics Holdings, Inc.自由现金流更多（$-5.9M vs $-7.0M）。过去两年奎斯特诊断的营收复合增速更高（154.4% vs -52.8%）
Cardio Diagnostics Holdings, Inc.是一家专注于精准心血管医疗的企业，开发并商业化整合遗传与表观遗传技术的诊断检测产品，可早期识别冠心病、心力衰竭等心血管疾病，主要服务美国市场的医疗机构、临床实验室与患者。
奎斯特诊断公司是一家美国临床检验企业，跻身财富500强，业务覆盖美国本土，以及波多黎各、墨西哥、巴西等地区，同时与全球多家医院和诊所保持合作关系，是行业内颇具影响力的医疗诊断服务提供商。
CDIO vs IMDX — 直观对比
营收规模更大
IMDX
是对方的320.4倍
$3.6K
营收增速更快
CDIO
高出2.1%
-23.4%
自由现金流更多
CDIO
多$1.1M
$-7.0M
两年增速更快
IMDX
近两年复合增速
-52.8%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $3.6K | $1.1M |
| 净利润 | — | $-23.0M |
| 毛利率 | — | 42.5% |
| 营业利润率 | — | -2057.5% |
| 净利率 | — | -2015.4% |
| 营收同比 | -21.2% | -23.4% |
| 净利润同比 | 3.6% | 31.5% |
| 每股收益（稀释后） | — | $-0.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CDIOIMDX
| Q4 25 | $3.6K | $1.1M | ||
| Q3 25 | $2.9K | $260.0K | ||
| Q2 25 | $7.5K | $518.0K | ||
| Q1 25 | $940 | $2.1M | ||
| Q4 24 | $4.5K | $1.5M | ||
| Q3 24 | $6.6K | $115.0K | ||
| Q2 24 | $7.9K | $104.0K | ||
| Q1 24 | $15.9K | $176.0K |
净利润CDIOIMDX
| Q4 25 | — | $-23.0M | ||
| Q3 25 | $-1.7M | $-10.9M | ||
| Q2 25 | $-1.7M | $-9.7M | ||
| Q1 25 | $-1.6M | $-6.7M | ||
| Q4 24 | — | $-33.5M | ||
| Q3 24 | $-1.4M | $-13.5M | ||
| Q2 24 | $-1.3M | $-4.5M | ||
| Q1 24 | $-4.2M | $-9.1M |
毛利率CDIOIMDX
| Q4 25 | — | 42.5% | ||
| Q3 25 | — | 53.5% | ||
| Q2 25 | — | 67.6% | ||
| Q1 25 | — | 62.0% | ||
| Q4 24 | — | 40.0% | ||
| Q3 24 | — | 43.5% | ||
| Q2 24 | — | 48.1% | ||
| Q1 24 | — | 25.6% |
营业利润率CDIOIMDX
| Q4 25 | — | -2057.5% | ||
| Q3 25 | -59950.9% | -4249.2% | ||
| Q2 25 | -22457.5% | -1900.0% | ||
| Q1 25 | -173463.8% | -318.0% | ||
| Q4 24 | — | -2262.9% | ||
| Q3 24 | -21412.9% | -11752.2% | ||
| Q2 24 | -16295.6% | -4453.8% | ||
| Q1 24 | -26105.3% | -5265.3% |
净利率CDIOIMDX
| Q4 25 | — | -2015.4% | ||
| Q3 25 | -60053.8% | -4174.6% | ||
| Q2 25 | -22517.7% | -1880.7% | ||
| Q1 25 | -173943.0% | -312.0% | ||
| Q4 24 | — | -2255.1% | ||
| Q3 24 | -21467.6% | -11733.0% | ||
| Q2 24 | -16365.9% | -4355.8% | ||
| Q1 24 | -26140.0% | -5186.9% |
每股收益（稀释后）CDIOIMDX
| Q4 25 | — | $-0.75 | ||
| Q3 25 | $-0.98 | $-0.34 | ||
| Q2 25 | $-0.97 | $-0.30 | ||
| Q1 25 | $-0.97 | $-0.26 | ||
| Q4 24 | — | $-2.19 | ||
| Q3 24 | $-1.73 | $-0.98 | ||
| Q2 24 | $-1.71 | $-0.36 | ||
| Q1 24 | $-5.93 | $-1.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $11.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $7.0M | $-31.5M |
| 总资产 | $7.8M | $25.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CDIOIMDX
| Q4 25 | — | $11.6M | ||
| Q3 25 | — | $18.7M | ||
| Q2 25 | — | $24.3M | ||
| Q1 25 | — | $31.0M | ||
| Q4 24 | — | $8.6M | ||
| Q3 24 | — | $3.4M | ||
| Q2 24 | — | $9.3M | ||
| Q1 24 | — | $5.6M |
股东权益CDIOIMDX
| Q4 25 | $7.0M | $-31.5M | ||
| Q3 25 | $8.2M | $-9.2M | ||
| Q2 25 | $9.7M | $1.1M | ||
| Q1 25 | $11.4M | $10.2M | ||
| Q4 24 | $9.6M | $-12.3M | ||
| Q3 24 | $3.7M | $9.7M | ||
| Q2 24 | $3.1M | $22.7M | ||
| Q1 24 | $3.0M | $11.6M |
总资产CDIOIMDX
| Q4 25 | $7.8M | $25.8M | ||
| Q3 25 | $8.8M | $43.9M | ||
| Q2 25 | $10.4M | $50.5M | ||
| Q1 25 | $12.3M | $60.4M | ||
| Q4 24 | $10.6M | $35.1M | ||
| Q3 24 | $4.5M | $70.2M | ||
| Q2 24 | $4.0M | $74.7M | ||
| Q1 24 | $4.3M | $71.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.7M | $-5.5M |
| 自由现金流经营现金流 - 资本支出 | $-5.9M | $-7.0M |
| 自由现金流率自由现金流/营收 | -166361.5% | -616.7% |
| 资本支出强度资本支出/营收 | 5269.1% | 129.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-10.5M | $-25.4M |
8季度趋势，按日历期对齐
经营现金流CDIOIMDX
| Q4 25 | $-5.7M | $-5.5M | ||
| Q3 25 | $-1.4M | $-4.5M | ||
| Q2 25 | $-1.6M | $-6.3M | ||
| Q1 25 | $-1.4M | $-5.9M | ||
| Q4 24 | $-5.0M | $-5.4M | ||
| Q3 24 | $-1.2M | $-5.5M | ||
| Q2 24 | $-1.2M | $-6.0M | ||
| Q1 24 | $-1.2M | $-3.8M |
自由现金流CDIOIMDX
| Q4 25 | $-5.9M | $-7.0M | ||
| Q3 25 | $-1.6M | $-5.6M | ||
| Q2 25 | $-1.6M | $-6.6M | ||
| Q1 25 | $-1.4M | $-6.2M | ||
| Q4 24 | $-5.2M | $-5.6M | ||
| Q3 24 | $-1.2M | $-5.6M | ||
| Q2 24 | $-1.4M | $-6.2M | ||
| Q1 24 | $-1.3M | $-3.9M |
自由现金流率CDIOIMDX
| Q4 25 | -166361.5% | -616.7% | ||
| Q3 25 | -54509.7% | -2135.4% | ||
| Q2 25 | -21273.1% | -1279.5% | ||
| Q1 25 | -149562.6% | -288.4% | ||
| Q4 24 | -115422.6% | -374.5% | ||
| Q3 24 | -17942.3% | -4884.3% | ||
| Q2 24 | -17513.3% | -5931.7% | ||
| Q1 24 | -7866.9% | -2189.8% |
资本支出强度CDIOIMDX
| Q4 25 | 5269.1% | 129.9% | ||
| Q3 25 | 5703.5% | 403.8% | ||
| Q2 25 | 250.1% | 67.4% | ||
| Q1 25 | 615.6% | 14.4% | ||
| Q4 24 | 4759.9% | 14.4% | ||
| Q3 24 | 353.3% | 75.7% | ||
| Q2 24 | 2133.4% | 183.7% | ||
| Q1 24 | 125.5% | 13.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
